Associate Director, Biostatistics, Clinical Late Stage

Revolution Medicines, an oncology company developing RAS(ON) tri-complex inhibitors, is hiring an Associate Director of Biostatistics for its clinical late-stage development team in Redwood City, CA. The role serves as study-level statistician for oncology studies in late-stage clinical development, representing biostatistics on study and cross-functional project teams and contributing to program-level decision-making. Responsibilities include providing statistical expertise for design, analysis, and reporting of clinical studies; developing statistical analysis plans and specifications; collaborating with statistical programming, data management, and clinical operations; and providing statistical input to regulatory submissions and health authority interactions. Candidates need a PhD (5+ years) or MS (8+ years) in statistics/biostatistics with hands-on experience in late-stage oncology trial design and analysis, and proficiency in SAS and/or R. The posted base pay range is $186,000 - $233,000 USD.